Windlas Biotech Ltd (WINDLAS)
·Next Day Close·-0.02%·₹1,099.3
Key EventTrading window closure announced for upcoming results
Windlas Biotech Ltd (WINDLAS)
·Next Day Close·+8.53%·₹1,093.5
Key EventWindlas Biotech announces virtual investor meeting schedule for September 7, 2026
ImpactShareholders should note the company is proactively engaging investors through scheduled virtual meetings without revealing new price-sensitive information.Sign up to read impact
Windlas Biotech Limited (WINDLAS)
·Next Day Close·-5.11%·₹895.15
Key EventCompany uploaded conference call audio for Q1 FY2026 results
ImpactShareholders can now access the recorded call to review management commentary on recent financial performance.Sign up to read impact
Windlas Biotech Limited (WINDLAS)
·Next Day Close·+11.77%·₹943.35
Key EventWindlas Biotech posted robust Q1 FY27 growth with 18% revenue increase and 37% PAT growth.
ImpactShareholders benefit from strong growth, healthy margins, and consistent capital returns amid expanding global markets.Sign up to read impact
Windlas Biotech Limited (WINDLAS)
·Next Day Close·+11.77%·₹943.35
Key EventBoard approved Q1 FY26 results and FY26 dividend
ImpactThe dividend approval and share buyback signal management's confidence in cash flow, but dissolution of the US subsidiary removes a reporting segment without immediate financial impact.Sign up to read impact
Windlas Biotech Limited (WINDLAS)
·Next Day Close·+11.77%·₹943.35
Key EventWindlas Biotech reports Q1 FY27 results with record revenue and dividend declaration
ImpactThe company delivered record revenue and profitability while returning capital to shareholders through dividend and buyback, signaling confidence in sustained growth.Sign up to read impact
Windlas Biotech Limited (WINDLAS)
·Next Day Close·+0.02%·₹859.5
Key Event25th AGM approved FY2025-26 audited financials and declared ₹6.30 final dividend per share
ImpactShareholders approved key governance and financial items, confirming dividend payout and director appointments.Sign up to read impact
Windlas Biotech Limited (WINDLAS)
·Next Day Close·+1.2%·₹871.7
Windlas Biotech announced completion of its 25th AGM and Annual Report for FY2025-26 via newspaper ads in Financial Express and Dainik Bhaskar on July 2, 2026, confirming regulatory compliance and website availability of documents.
Sign up to read summaryWindlas Biotech Limited (WINDLAS)
·Next Day Close·-0.05%·₹861.4
Windlas Biotech announced its 25th AGM on July 23, 2026, via video conference, proposing a final dividend of ₹6.30 per share (126% of face value) and reappointing directors Hitesh Windlass and Prachi Jain Windlass. Dr. Tarashree Singhal will be appointed as an Independent Director for five years, with resolutions on auditor remuneration and director appointments to be voted on. Shareholders must update PAN, residential status, and bank mandates by July 16, 2026, to receive dividends via ECS, while remote e-voting via InstaVote and MUFG Intime is open from July 20-22, 2026, requiring OTP-based login and compliance with SEBI regulations.
Sign up to read summaryWindlas Biotech Limited (WINDLAS)
·Next Day Close·-0.05%·₹861.4
Windlas Biotech announced its 25th AGM on July 23, 2026, with a record date of July 16, 2026, to determine shareholders eligible for a recommended dividend of Rs. 6.30 per share, representing 126% on a Rs. 5 face value, for the financial year 2025-26.
Sign up to read summary